Search
for
Sort by
Research 211–240 of 1000+
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Chemotherapy for children with medulloblastoma
- Methotrexate for maintenance of remission in ulcerative colitis
- From the Cochrane Library: Interventions for Nail Psoriasis
- Combination of Intense Pulsed Light and Topical Eflornithine Therapy Versus Intense Pulsed Light Alone in the Treatment of Idiopathic Facial Hirsutism: A Randomized Controlled Trial
- Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study
- Topical imiquimod—Be aware of the unexpected
- Exosome-Based Therapies in Dermatology: A Scoping Review
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Short communication: Clinical evaluation of pea sprout extract in the treatment of hair loss
- Chemical lumbar sympathectomy in the treatment of idiopathic livedo reticularis
- Dermatological adverse events with taxane chemotherapy
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Feasibility and acceptability of an online multicomponent very low-carbohydrate intervention in young adult women with obesity: a pilot study
- Laser-based interventions for scarring alopecia: a meta-analytic review of clinical outcomes
- Botulinum Toxins in Medical and Cosmetic Dermatology
- Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database